MKI67 as a potential diagnostic biomarker in pulmonary hypertension.

ABSTRACT:

Background

Right heart failure results from advanced pulmonary hypertension (PH) and has a poor prognosis. There are few available treatments for right heart failure. Pulmonary artery remodeling, including changes in pulmonary artery endothelial cells to endothelial-mesenchymal cells, and aberrant fibroblast and pulmonary artery smooth muscle cell (PASMC) proliferation, are characteristics of the pathophysiological process of PH. As a result, the clinical situation requires novel PH diagnostic and treatment targets.

Methods

Monocrotaline was used to create an animal model of PH, and lung tissue was removed for transcriptome sequencing. The targets with the highest differences were chosen for transfection after possible targets were identified using bioinformatic techniques a

SUBMITTER: Zhou H 

PROVIDER: S-EPMC9663476 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature